Cellulitis of the lower leg is an infection caused by streptococci or, less commonly, Staphylococcus aureus and other gram-negative rods. Recurrence of cellulitis is a common problem. In the present study, we evaluated the use of monthly intramuscular injections of benzathine penicillin G to prevent recurrences of cellulitis. A total of 115 patients with definite or presumptive cases of streptococcal cellulitis were enrolled in this study. Eighty-four of these patients who declined follow-up or received incomplete prophylaxis were considered controls. Recurrence occurred in four (12.9%) of 31 cases who received prophylaxis and 16 (19%) of the 84 cases who did not receive prophylaxis. The difference was not statistically significant. Predisposing factors for cellulitis were found in 57 (49.6%) of the 115 enrolled cases and were mostly related to the impairment of local circulation. Administration of prophylaxis successfully reduced the recurrence rate to zero among patients without predisposing factors but failed to prevent recurrence in those with predisposing factors (20%). We conclude that monthly benzathine penicillin G prophylaxis benefits only patients without predisposing factors for cellulitis.
Cellulitis of the lower leg is an acute, spreading infection riod September 1990 through June 1995 with the clinical diagnosis of lower-leg cellulitis were enrolled in our study. A series of the skin or subcutaneous tissues that is caused by group A streptococci, Staphylococcus aureus, and, less commonly, other of evaluations were done for the patients who were enrolled; these evaluations included two sets of blood cultures, culture species of streptococci [1 -3] . The usual portals of entry include skin ulcers, local trauma or abrasions, psoriatic or eczematous and gram staining of subcutaneous fluid aspirated from the active margins of cellulitis, assay for antibodies to serum streplesions, or fungal infections. In tropical areas, tinea pedis is the most important portal of entry, since it is a common affliction tolysin O (EIKEN, Tokyo, Japan), and determination of clinical responses to treatment with 3 megaunits of intravenous penicilbecause of the humid climate. Predisposing factors for cellulitis include venous stasis, obesity, leg edema, fracture, diabetes lin G every 6 hours for 1 -2 weeks. We defined definite streptococcal cellulitis by cultures of either blood or subcutaneous mellitus, previous vascular or orthopedic surgery, and lymphedema. Cellulitis is easily treated with antibiotics; however, fluid positive for streptococci, a fourfold rise in titers of antibodies to streptolysin O in serum samples drawn ú2 weeks recurrence is not unusual, especially in patients with predisposing factors [1, 4 -6] .
apart, or as a single titer of antibody to streptolysin O that was ú333 (a cutoff value accepted in Taiwan). Benzathine penicillin G, a slow-releasing penicillin, is the preferred prophylactic agent for preventing recurrences of rheuPatients without microbiological or serological evidence of streptococcal infection who responded to treatment with matic fever [7 -9] . In the present study, we evaluated the use of this agent as prophylaxis for cellulitis. For the past 5 years, intravenous benzathine penicillin G were classified as presumptive cases of streptococcal cellulitis. Patients with culall patients admitted to our hospital with streptococcal cellulitis of the lower legs were advised to receive benzathine penicillin tures positive for bacteria other than streptococci were excluded from the study. Culture-negative cases who failed G prophylaxis after completing a 1 -2 week course of intravenous aqueous penicillin G treatment. The results of this study to respond to intravenous benzathine penicillin G treatment within 1 week were also excluded and classified as nonstrepgave us an objective view of the effectiveness of prophylaxis for recurrences of cellulitis. tococcal cellulitis. Evaluation of predisposing factors. Of the 115 enrolled follow-up. Two recurrences were proven by serology, and 14 were diagnosed presumptively as streptococcal cellulitis. Of the cases with cellulitis, 57 (49.6%) had predisposing factors for the infection (table 3) , including 23 (20%) with diabetes melli-31 cases who received a complete 1-year course of benzathine penicillin G prophylaxis, four (12.9%) had recurrences while tus, 15 (13%) with impaired venous drainage (five had varicose veins, four had deep-venous thrombosis, three had stasis derreceiving prophylaxis. The difference was not statistically significant. Five recurrences occurred in these four cases. The five matitis, and three had undergone coronary artery bypass graft), 16 (13.9%) with lower-leg edema (eight had congestive heart recurrences occurred on the 20th, 20th, 21st, 26th, and 30th days after the last prophylactic injection was administered. failure, four had cirrhosis of the liver, two were obese, one had myxedema, and one was pregnant), 6 (5.2%) with previous Of the 14 controls who received incomplete prophylaxis, two had a recurrence of cellulitis (one had a recurrence while tibial fractures, 4 (3.5%) with filariasis, and one (0.9%) who had undergone total knee replacement. The ratio of cases with receiving prophylaxis, and the other had a recurrence after penicillin G to improve prophylactic efficacy.
for cellulitis of prophylaxis of controls (%)
Although the most prevalent predisposing factor for cellulitis in our study was diabetes mellitus (20% of our cases), the circulation. The presence of predisposing factors is a major determinant of recurrences in patients receiving prophylaxis. In our report, all five episodes of recurrences during prophylaxis occurred in patients with predisposing factors for cellulitis. prophylaxis was discontinued). The only case of recurrence This raises a serious problem because patients with predisposduring prophylaxis also occurred on the 22nd day after the ing factors for cellulitis are the ones who have the most recurlast prophylactic injection. Eight (21.6%) of 37 controls with rent attacks of cellulitis and are in need of an effective prophypredisposing factors and eight (17%) of 47 controls without lactic agent to terminate these recurrences. As discussed predisposing factors had a recurrence during the 1-year followpreviously, shortening the prophylactic interval or increasing up period. The difference was not significant. Four (20%) of 20 the dosage of benzathine penicillin G may be helpful. cases who received complete prophylaxis and had predisposing
We conclude that a monthly prophylactic intramuscular infactors and none of 11 cases who received complete prophyjection of 1.2 megaunits of benzathine penicillin G does not laxis and did not have predisposing factors had recurrences provide a major advantage over no prophylaxis in preventing during prophylaxis.
recurrences of cellulitis. Shortening of the prophylactic interval to 2 weeks or increasing the dosage of benzathine penicillin G to 3.6 or 4.8 megaunits is potentially more effective in preventing recurrences. However, it remains debatable whether Discussion it is worthwhile to administer prophylaxis that requires such frequent injections or such high doses of penicillin to prevent Although streptococcal cellulitis is an uncomfortable infection of the lower legs, it is not serious. In our clinical experia relatively uncomplicated infectious disease with a relatively low natural recurrence rate (17.8%). ence, a single episode of cellulitis is easy to treat, but recurrences are a common and difficult problem. The current Impairment of the local circulation is a major predisposing factor for cellulitis or erysipelas. However, the presence of literature provides limited information concerning the risk factors for and incidence and management of recurrences [10, 11] .
predisposing factors for cellulitis is not a risk factor for recurrence in patients who do not receive prophylaxis. Recurrences We found that the mean recurrence rate was 19.0% within 1 year among controls who declined to follow up (table 4), and occur only in patients with predisposing factors who receive prophylaxis. Prophylaxis can reduce the recurrence rate from there was only a small difference in recurrence rates between patients with and without predisposing factors (21.6% vs.
17.0% to 0 among patients without predisposing factors, but this is not the case for patients with predisposing factors. If 17.0%). This is a surprising result, since predisposing factors had always been viewed as essential to the recurrence of cellulimonthly benzathine penicillin G prophylaxis is indicated, the best candidates are patients without predisposing factors for tis. On the basis of this study, we now know that the incidence of recurrent cellulitis is the same among patients with prediscellulitis. For patients with predisposing factors, we believe that shortening the prophylactic interval to 2 weeks or increasposing factors as among those without predisposing factors.
The rate of recurrence declined to 12.9% (P Å .5634725; ing the dosage of benzathine penicillin G to 3.6 or 4.8 megaunits per month may improve the drug's efficacy in preventing OR Å 1.69) among cases who received monthly benzathine penicillin G prophylaxis for 1 year. This finding was not statistirecurrences. cally significant. However, in all cases where recurrences oc-
